LOGO
LOGO

Email This Article

BioXcel Therapeutics Sets 1-for-16 Reverse Stock Split To Regain Nasdaq Listing
To Email: *
Bcc: Seperate multiple addresses with commas(,)
Your Email: *
Format :

* Denotes Required Fields